+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tissue Heart Valves (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 80 Pages
  • October 2021
  • Region: Global
  • GlobalData
  • ID: 5460010
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Tissue Heart Valves (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

Summary


This Medical Devices sector report, “Tissue Heart Valves (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Tissue Heart Valves pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Tissue heart valve are a combination of tissue and synthetic biomaterials with the tissue itself being flexible. Bovine and porcine valves are included here.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope


  • Extensive coverage of the Tissue Heart Valves under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Heart Valves and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy


The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Heart Valves under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Tissue Heart Valves Overview
3 Products under Development
3.1 Tissue Heart Valves - Pipeline Products by Stage of Development
3.2 Tissue Heart Valves - Pipeline Products by Segment
3.3 Tissue Heart Valves - Pipeline Products by Territory
3.4 Tissue Heart Valves - Pipeline Products by Regulatory Path
3.5 Tissue Heart Valves - Pipeline Products by Estimated Approval Date
3.6 Tissue Heart Valves - Ongoing Clinical Trials
4 Tissue Heart Valves - Pipeline Products under Development by Companies
4.1 Tissue Heart Valves Companies - Pipeline Products by Stage of Development
4.2 Tissue Heart Valves - Pipeline Products by Stage of Development
5 Tissue Heart Valves Companies and Product Overview
5.1 Anchorvalve Company Overview
5.1.1 Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview
5.2 Biostage Inc Company Overview
5.2.1 Biostage Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Boston Children's Hospital Company Overview
5.3.1 Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.4 Colibri Heart Valve LLC Company Overview
5.4.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
5.5 CorMatrix Cardiovascular Inc Company Overview
5.5.1 CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 CroiValve Ltd Company Overview
5.6.1 CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.7 CryoLife Inc Company Overview
5.7.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Cytograft Tissue Engineering Inc (Inactive) Company Overview
5.8.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.9 Daidalos Solutions BV Company Overview
5.9.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
5.10 Edwards Lifesciences Corp Company Overview
5.10.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
5.11 Hancock Jaffe Laboratories Inc Company Overview
5.11.1 Hancock Jaffe Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Medtronic Plc Company Overview
5.12.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Meril Life Sciences Pvt Ltd Company Overview
5.13.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.14 National University of Singapore Company Overview
5.14.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
5.15 Revivicor Inc Company Overview
5.15.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.16.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
5.17 Stellenbosch University Company Overview
5.17.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview
5.18 Tissue Regenix Ltd Company Overview
5.18.1 Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.19 University of California Irvine Company Overview
5.19.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
5.20 University of Cambridge Company Overview
5.20.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
5.21 University of Zurich Company Overview
5.21.1 University of Zurich Pipeline Products & Ongoing Clinical Trials Overview
5.22 ValveXchange, Inc. (Inactive) Company Overview
5.22.1 ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.23 Venus Haoyue Medtech Ltd Company Overview
5.23.1 Venus Haoyue Medtech Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.24 VueKlar Cardiovascular Ltd (Inactive) Company Overview
5.24.1 VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6 Tissue Heart Valves- Recent Developments
6.1 Sep 22, 2021: Anthony Semedo Joins CryoLife Board of Directors
6.2 Jul 29, 2021: CryoLife Reports Second Quarter 2021 Financial Results
6.3 Jul 29, 2021: Edwards Lifesciences Announces financial results for the quarter ended June 30, 2021
6.4 Jul 28, 2021: LivaNova Reports Second Quarter 2021 Results and Appoints Alex Shvartsburg as Chief Financial Officer
6.5 Jul 22, 2021: Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021
6.6 Jul 15, 2021: CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results
6.7 May 05, 2021: Edwards Announces Updates From Annual Meeting
6.8 May 05, 2021: University of Cambridge appoints Dr Diarmuid O’Brien as new Chief Executive of Cambridge Enterprise
6.9 Apr 29, 2021: CryoLife Reports First Quarter 2021 Financial Results
6.10 Apr 28, 2021: Tissue Regenix Group Announces final results for the year ended 31 December 2020
6.11 Mar 09, 2021: CryoLife to Participate in Oppenheimer 31st Annual Virtual Healthcare Conference
6.12 Feb 26, 2021: Tissue Regenix Announces Directorate Change
6.13 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
6.14 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.15 Feb 11, 2021: CryoLife Reports Fourth Quarter and Full Year 2020 Financial Results
6.16 Jan 28, 2021: CryoLife Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2020 Financial Results
6.17 Jan 20, 2021: LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2020 Results
6.18 Jan 13, 2021: Edwards Lifesciences To Host Earnings Conference Call On January 27, 2021
6.19 Oct 21, 2020: CryoLife Announces Release Date and Teleconference Call Details for 2020 Third Quarter Financial Results
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Tissue Heart Valves - Pipeline Products by Stage of Development
  • Tissue Heart Valves - Pipeline Products by Segment
  • Tissue Heart Valves - Pipeline Products by Territory
  • Tissue Heart Valves - Pipeline Products by Regulatory Path
  • Tissue Heart Valves - Pipeline Products by Estimated Approval Date
  • Tissue Heart Valves - Ongoing Clinical Trials
  • Tissue Heart Valves Companies - Pipeline Products by Stage of Development
  • Tissue Heart Valves - Pipeline Products by Stage of Development
  • Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview
  • Sutureless Mitral Valve Prostheses - Product Status
  • Sutureless Mitral Valve Prostheses - Product Description
  • Sutureless Tricuspid Valve Prostheses - Product Status
  • Sutureless Tricuspid Valve Prostheses - Product Description
  • Biostage Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 3D Printed Heart Valve - Product Status
  • 3D Printed Heart Valve - Product Description
  • Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • Heart Valve Leaflet - Product Status
  • Heart Valve Leaflet - Product Description
  • Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Pulmonary Valve - Product Status
  • Pulmonary Valve - Product Description
  • Sutureless Surgical Aortic Valve - Product Status
  • Sutureless Surgical Aortic Valve - Product Description
  • CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Cor PEDIATRIC Tricuspid ECM Valve - Product Status
  • Cor PEDIATRIC Tricuspid ECM Valve - Product Description
  • CorMatrix Cor TRICUSPID ECM Valve Device - Product Status
  • CorMatrix Cor TRICUSPID ECM Valve Device - Product Description
  • CorMatrix ECM - Heart Valve Repair - Product Status
  • CorMatrix ECM - Heart Valve Repair - Product Description
  • CorMatrix ECM - Heart Valve Replacement - Product Status
  • CorMatrix ECM - Heart Valve Replacement - Product Description
  • Regenerating Tubular Mitral Valve - Product Status
  • Regenerating Tubular Mitral Valve - Product Description
  • CorMatrix Cardiovascular Inc - Ongoing Clinical Trials Overview
  • Cor PEDIATRIC Tricuspid ECM Valve - CorMatrix Cor TRICUSPID ECM Valve Replacement Safety and Early Feasibility
  • CorMatrix Cor TRICUSPID ECM Valve Device - CorMatrix Cor TRICUSPID ECM Valve Replacement Safety and Early Feasibility
  • CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Duo Tricuspid Coaptation Valve - Product Status
  • Duo Tricuspid Coaptation Valve - Product Description
  • CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
  • CryoValve SGAV - Product Status
  • CryoValve SGAV - Product Description
  • Synergraft Xenograft Heart Valve - Product Status
  • Synergraft Xenograft Heart Valve - Product Description
  • Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Cytograft Valve - Product Status
  • Cytograft Valve - Product Description
  • Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
  • Sutureless Aortic Valve Prosthesis - Product Status
  • Sutureless Aortic Valve Prosthesis - Product Description
  • Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Edwards INSPIRIS RESILIA Aortic Valve - Product Status
  • Edwards INSPIRIS RESILIA Aortic Valve - Product Description
  • GLX Aortic Conduit - Product Status
  • GLX Aortic Conduit - Product Description
  • Magna EASE Surgical Valve With GLX - Product Status
  • Magna EASE Surgical Valve With GLX - Product Description
  • Mitris Resilia - Product Status
  • Mitris Resilia - Product Description
  • Edwards Lifesciences Corp - Ongoing Clinical Trials Overview
  • Magna EASE Surgical Valve With GLX - Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients
  • Edwards INSPIRIS RESILIA Aortic Valve - Clinical Outcomes of Patients Under the Age of Sixty Undergoing INSPIRIS RESILIA Aortic Valve Replacement
  • Edwards INSPIRIS RESILIA Aortic Valve - INSPIRIS RESILIA Aortic Valve, Valve-in-valve Surveillance Study
  • Edwards INSPIRIS RESILIA Aortic Valve - Prospective Non-randomized Single Arm Multi-center Evaluation of the Durability of Aortic Bioprostheses/Valves with RESILIA Tissue in Subjects under 65 (RESILIENCE Trial)
  • Edwards INSPIRIS RESILIA Aortic Valve - Surgical Aortic Valve Replacement: IMPACT of Pre-existing Comorbidities on Patient Outcomes and Prosthetic Valve Performance in a Real-world Setting
  • Hancock Jaffe Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Bioprosthetic Aortic Heart Valve - Product Status
  • Bioprosthetic Aortic Heart Valve - Product Description
  • Bioprosthetic Mitral Heart Valve - Product Status
  • Bioprosthetic Mitral Heart Valve - Product Description
  • Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Closed-Chest Aortic Tissue Valve - Product Status
  • Closed-Chest Aortic Tissue Valve - Product Description
  • Enable Valve - Beating Heart Procedure - Product Status
  • Enable Valve - Beating Heart Procedure - Product Description
  • Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Daffodil AV - Product Status
  • Daffodil AV - Product Description
  • Daffodil MV - Product Status
  • Daffodil MV - Product Description
  • DAFODIL DRI - Product Status
  • DAFODIL DRI - Product Description
  • National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
  • SingValve - Product Status
  • SingValve - Product Description
  • Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Heart Valve - Product Status
  • Heart Valve - Product Description
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Tissue Based Cardiac Valve - Product Status
  • Tissue Based Cardiac Valve - Product Description
  • Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview
  • Percutaneous Heart Valve - Product Status
  • Percutaneous Heart Valve - Product Description
  • Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Cardiopure - Aortic Heart Valve - Product Status
  • Cardiopure - Aortic Heart Valve - Product Description
  • Cardiopure - Pulmonary Heart Valve - Product Status
  • Cardiopure - Pulmonary Heart Valve - Product Description
  • University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
  • Bileaflet Bioprosthetic Mitral Valve - Product Status
  • Bileaflet Bioprosthetic Mitral Valve - Product Description
  • Heart Valve Leaflets - Product Status
  • Heart Valve Leaflets - Product Description
  • University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
  • Polivalve - Product Status
  • Polivalve - Product Description
  • University of Zurich Pipeline Products & Ongoing Clinical Trials Overview
  • Prostheses Heart Valve - Product Status
  • Prostheses Heart Valve - Product Description
  • ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Vanguard System - Product Status
  • Vanguard System - Product Description
  • Vitality Exchangeable Valve System - Product Status
  • Vitality Exchangeable Valve System - Product Description
  • VXi Vanguard II - Product Status
  • VXi Vanguard II - Product Description
  • Venus Haoyue Medtech Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Sutureless Aortic Valve - Product Status
  • Sutureless Aortic Valve - Product Description
  • VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • MR-Enhancing Percutaneous Heart Valve - Product Status
  • MR-Enhancing Percutaneous Heart Valve - Product Description
  • Glossary

List of Figures
  • Tissue Heart Valves - Pipeline Products by Stage of Development
  • Tissue Heart Valves - Pipeline Products by Segment
  • Tissue Heart Valves - Pipeline Products by Territory
  • Tissue Heart Valves - Pipeline Products by Regulatory Path
  • Tissue Heart Valves - Pipeline Products by Estimated Approval Date
  • Tissue Heart Valves - Ongoing Clinical Trials

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Anchorvalve
  • Biostage Inc
  • Boston Children's Hospital
  • Colibri Heart Valve LLC
  • CorMatrix Cardiovascular Inc
  • CroiValve Ltd
  • CryoLife Inc
  • Cytograft Tissue Engineering Inc (Inactive)
  • Daidalos Solutions BV
  • Edwards Lifesciences Corp
  • Hancock Jaffe Laboratories Inc
  • Medtronic Plc
  • Meril Life Sciences Pvt Ltd
  • National University of Singapore
  • Revivicor Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stellenbosch University
  • Tissue Regenix Ltd
  • University of California Irvine
  • University of Cambridge
  • University of Zurich
  • ValveXchange, Inc. (Inactive)
  • Venus Haoyue Medtech Ltd
  • VueKlar Cardiovascular Ltd (Inactive)